TP53 and non-small cell lung carcinoma: In the latter paper, NSCLC patients (n = 104) were screened according to the levels of the well-known gene mutations, such as K-Ras, p53, etc, versus protein levels, such as CEA, CA-125, CA19-9, osteopontin, etc. [20].